News | Computed Tomography (CT) | December 17, 2020

Fujifilm Announces CT Partnership with Leading Urology Group UroPartners

Largest urology practice with 30+ locations and 90+ providers standardizes their practice with the Persona CT computed tomography system for advanced oncology treatment planning

 Fujifilm Medical Systems U.S.A., Inc. announced today that UroPartners, the largest urology practice in Illinois and top five in the nation, has chosen to standardize on the Persona CT computed tomography (CT) system to accelerate their oncology treatment planning capabilities

December 17, 2020 — Fujifilm Medical Systems U.S.A., Inc. announced that UroPartners, the largest urology practice in Illinois and top five in the nation, has chosen to standardize on the Persona CT computed tomography (CT) system to accelerate their oncology treatment planning capabilities. Designed and built in the U.S., the Persona CT is an innovative CT system from Fujifilm in partnership with Analogic. The system offers advanced oncology simulation and general radiography imaging capabilities with a focus on the patient experience.

"We were looking for a state-of-the-art oncology CT system that improves our patients experiences, ensures speed, comfort and accuracy with every CT scan," said William Andre at UroPartners, in explaining his facility's decision to select the Persona CT. "The Persona CT's wide open bore and forward thinking design features, like metal artifact reduction and 4-D gating made it a clear choice in selecting Fujifilm as our partner to propel us into the future. As a leading urology group in the Midwest, we are committed to investing in the latest and best technologies available to ensure our patients receive the most accurate treatments and best results possible in a comfortable environment."

The Persona CT includes a large, 85 cm bore which brings a more comfortable exam for patients of all sizes, while also simplifying the accuracy of the patient's radiation treatment planning by uniquely matching the arc of the linear accelerator. Other competitive features include fast and precise 64/128 slice imaging, which allows the system to generate submillimeter high resolution images in any dimension. Faster scans means less burden on patients, especially those that have difficulty holding their breath or position.

 "We're delighted that UroPartners entrusts Fujifilm to drive accuracy for oncology treatment planning," said Rick Banner, Senior Director of Marketing, Modality Solutions, Fujifilm Medical Systems U.S.A., Inc. "Built from the ground up, the Persona CT is equipped with best-in-class detector and system design, advanced image-processing technologies and high rotational speed to provide unparalleled precision and accuracy for accurate ROI identification and tumor volume."

Patients will be able to receive their CT scans on the Persona CT at the UroPartners' Gurnee location. For more information on the Persona CT: https://www.fujifilmhealthcare.com/computed-tomography

Related Content

New software-based application helps clinicians visualize breast anatomy and provides detailed characterization of lesions
News | Breast Imaging | December 17, 2020
December 17, 2020 — Hologic, Inc.
Cerner Corporation announced an agreement to acquire Kantar Health, a division of Kantar Group, for $375 million in cash, subject to adjustment
News | Radiology Business | December 16, 2020
December 16, 2020 — Cerner Corporation announced an agreement to acquire...
A recent Johns Hopkins Medicine study uses a computer model to predict the number of COVID-19 infections among health care workers in four different scenarios based on data from early in the pandemic. Graphic created by M.E. Newman, Johns Hopkins Medicine, from data in Razzak et al, PLOS ONE 15(12): e0242589

A recent Johns Hopkins Medicine study uses a computer model to predict the number of COVID-19 infections among health care workers in four different scenarios based on data from early in the pandemic. Graphic created by M.E. Newman, Johns Hopkins Medicine, from data in Razzak et al, PLOS ONE 15(12): e0242589

News | Coronavirus (COVID-19) | December 16, 2020
December 16, 2020 — During the COVID-19 pandemic
The Radiological Society of North America’s 106th Scientific Assembly and Annual Meeting (RSNA 2020) held November 30 to December 5 as an entirely virtual event, attracted a virtual audience of 29,339 people from 134 countries worldwide.

Getty Images

News | RSNA | December 15, 2020
December 15, 2020 — The Radiological Society of North America’s
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium

Getty Images

News | Radiation Therapy | December 15, 2020
December 15, 2020 — Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy
CXCR4-directed PET correlates with MRI-determined lymphoma lesions. Depicted are representative MR images (T1c- and FLAIR- sequences), and the corresponding CXCR4- directed PET images and fusion images (MRI-FLAIR and PET), of two patients with PCNSL and SCNSL, respectively. Images created by Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.

CXCR4-directed PET correlates with MRI-determined lymphoma lesions. Depicted are representative MR images (T1c- and FLAIR- sequences), and the corresponding CXCR4- directed PET images and fusion images (MRI-FLAIR and PET), of two patients with PCNSL and SCNSL, respectively. Images created by Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.

News | PET Imaging | December 14, 2020
December 14, 2020 — Positron emission tomography (PET) imaging with...